We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

COVID-19 Community Research Partnership

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04342884
Recruitment Status : Recruiting
First Posted : April 13, 2020
Last Update Posted : May 27, 2022
Sponsor:
Collaborators:
Centers for Disease Control and Prevention
North Carolina Department of Health and Human Services
Information provided by (Responsible Party):
Wake Forest University Health Sciences

Brief Summary:
The purpose of this research is to collect information about the North Carolina community's coronavirus exposures, symptoms, and health care visits due to the virus. Participation in this study will involve completing a daily questionnaire which covers participants coronavirus illness history or symptoms, health care seeking behaviors and treatments, contact with other sick people, and for health care workers, their use of personal protective equipment.

Condition or disease
Coronavirus COVID

Detailed Description:
Investigators will conduct a prospective, cohort study for SARS-CoV-2 infections among clients and health care workers of Wake Forest Baptist Health (WFBH). Investigators will conduct real-time syndromic respiratory disease surveillance and, for SARS-CoV-2 infections, calculate baseline seroprevalence and seroconversion rates, hazard risks from close contacts, estimate efficacy of personal protective equipment, and assess sequelae incidence. Investigators will utilize the COVID-19 Therapeutic Learning System, an Oracle developed self-reporting data collection system that can be easily modified to address these specific questions. Over the course of the study, volunteers will report daily exposures, risk reduction behaviors, and symptoms through a secure app on their smartphone, tablet, or computer. In addition to daily syndromic surveillance, at baseline and once every month after that we will use a serologic IgM/G test kit to identify infections and reinfections in volunteers and send results to the Oracle developed database. The areas covered by this study are experiencing community spread of COVID-19 but are early enough in the epidemic to capture potentially a significant number of seroconversions over the 12 months of the study. This surveillance model will be expanded to include the clients and health workers of other medical agencies in North Carolina and in other states.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 150000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Multicenter, Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records
Actual Study Start Date : April 8, 2020
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : March 2023

Resource links provided by the National Library of Medicine


Group/Cohort
Clients of Wake Forest Baptist Health (WFBH)
Health care workers of Wake Forest Baptist Health (WFBH)



Primary Outcome Measures :
  1. Seroprevalence of SARS-CoV-2 infection in the general population of North Carolina [ Time Frame: baseline ]
    Percent of volunteers who are 2019-nCoV Ab test positive

  2. Seroprevalence of SARS-CoV-2 infection among health care workers of North Carolina [ Time Frame: baseline ]
    Percent of volunteers who are 2019-nCoV Ab test positive


Secondary Outcome Measures :
  1. Cumulative incidence of SARS-CoV-2 infection [ Time Frame: 12 month ]
  2. Monthly incidence of SARS-CoV-2 infection [ Time Frame: Month 1 thru month 12 ]
  3. Stratified incidence of SARS-CoV-2 infection by age group [ Time Frame: Month 1 thru month 12 ]
  4. Stratified incidence of SARS-CoV-2 infection by sex [ Time Frame: Month 1 thru month 12 ]
  5. Stratified incidence of SARS-CoV-2 by season [ Time Frame: Month 1 thru month 12 ]
  6. Stratified incidence of SARS-CoV-2 infection by geographic area (zip code) [ Time Frame: Month 1 thru month 12 ]
  7. Stratified incidence of SARS-CoV-2 infection by preexisting comorbidities [ Time Frame: Month 1 thru month 12 ]
  8. Stratified incidence of SARS-CoV-2 infection by COVID-2 contacts [ Time Frame: Month 1 thru month 12 ]
  9. Stratified incidence of SARS-CoV-2 infection by use of personal protective equipment (PPE) by health workers [ Time Frame: Month 1 thru month 12 ]
  10. Relative risk of SARS-CoV-2 infection by age group [ Time Frame: Month 1 thru month 12 ]
  11. Relative risk of SARS-CoV-2 infection by sex [ Time Frame: Month 1 thru month 12 ]
  12. Relative risk of SARS-CoV-2 infection by season [ Time Frame: Month 1 thru month 12 ]
  13. Relative risk of SARS-CoV-2 infection by geographic area (zip code) [ Time Frame: Month 1 thru month 12 ]
  14. Relative risk of SARS-CoV-2 infection by preexisting comorbidities [ Time Frame: Month 1 thru month 12 ]
  15. Relative risk of SARS-CoV-2 infection by COVID-2 contacts [ Time Frame: Month 1 thru month 12 ]
  16. Relative risk of SARS-CoV-2 infection by use of PPE by health workers [ Time Frame: Month 1 thru month 12 ]
  17. Incidence of sequelae [ Time Frame: Month 1 thru month 12 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Investigators will seek enrollment of the clients and health care workers from diverse hospitals and clinics of WFBH.
Criteria

Inclusion Criteria:

  • All clients and health care worker of WFBH are eligible for enrollment.

Exclusion Criteria:

  • Health care workers who do not receive medical services through WFBH will not be enrolled.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04342884


Contacts
Layout table for location contacts
Contact: Wake Forest Baptist Medical Center 336-70-COVID jwsander@wakehealth.edu

Locations
Layout table for location information
United States, Louisiana
Tulane University School of Public Health and Tropical Medicine Recruiting
New Orleans, Louisiana, United States, 70112
United States, Maryland
University of Maryland School of Medicine Recruiting
Baltimore, Maryland, United States, 21201
Medstar Health Recruiting
Columbia, Maryland, United States, 21044
United States, Mississippi
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
United States, North Carolina
Atrium Health Recruiting
Charlotte, North Carolina, United States, 28202
Vidant Health Recruiting
Greenville, North Carolina, United States, 27834
Campbell University School of Osteopathic Medicine Recruiting
Lillington, North Carolina, United States, 27546
New Hanover Regional Medical Center Recruiting
Wilmington, North Carolina, United States, 28401
Wake Forest Baptist Health Recruiting
Winston-Salem, North Carolina, United States, 27157
Wake Forest Baptist Medical Center Recruiting
Winston-Salem, North Carolina, United States, 27157
WakeMed Health and Hospitals Recruiting
Winston-Salem, North Carolina, United States, 27157
Sponsors and Collaborators
Wake Forest University Health Sciences
Centers for Disease Control and Prevention
North Carolina Department of Health and Human Services
Investigators
Layout table for investigator information
Principal Investigator: John W Sanders, MD, MPH&TM Wake Forest University Health Sciences
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Wake Forest University Health Sciences
ClinicalTrials.gov Identifier: NCT04342884    
Obsolete Identifiers: NCT04361123
Other Study ID Numbers: IRB00064912
FP00000129 ( Other Grant/Funding Number: North Carolina Department of Health and Human Services )
SC-75D30120C08405 ( Other Identifier: Centers for Disease Control and Prevention )
First Posted: April 13, 2020    Key Record Dates
Last Update Posted: May 27, 2022
Last Verified: May 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Wake Forest University Health Sciences:
COVID-19
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases